JLABS

Primary contact

JLABS is Johnson & Johnson Innovation's global network of incubators and incubation partnerships to support entrepreneurs launching consumer, medical device, or biopharmaceutical companies. It helps startups remove business, financial and operational obstacles so that they can do what they do best, focus on the science and bringing innovative solutions to patients. JLABS's capital-efficient and flexible platform provides early-stage companies with many of the advantages of being at a big company while preserving an entrepreneur's equity and freedom to drive his or her science forward. JLABS is a "no-strings-attached" arrangement. There is no first look, no first right of refusal and no equity assigned to Johnson & Johnson or Janssen. Companies residing at JLABS gain immediate access to core research facilities hosting specialized capital equipment, as well as shared administrative areas. Additionally, JLABS produces a year-round curriculum designed to assist innovators along the product development continuum.
Primary contact

Last update: February 6, 2018